Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | less than 1 min read | 04.21.26
Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.
Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates.
The financing transaction was led by partner Kurt Machemer (Boston).
Read more here.
Insights
Firm News | 1 min read | 09.10.26
Amy Karnikian Recognized Among Business Aviation’s 2026 Top 40 Under 40
Los Angeles – September 10, 2026: The National Business Aviation Association (NBAA) has named Crowell & Moring’s Amy Karnikian to its 2026 Business Aviation Top 40 Under 40 list in the Business Management category. The annual recognition honors emerging leaders whose professional achievements, community involvement, innovative thinking, and commitment are helping shape the future of business aviation.
Firm News | 2 min read | 09.02.26
Chiraag Shah Joins Crowell & Moring’s International Dispute Resolution Practice in London
Firm News | 7 min read | 08.26.26
Firm News | 1 min read | 08.24.26
